Sulfadiazine
規格
68-35-9CAS番号
200-685-8EC番号
4-amino-N-pyrimidin-2-ylbenzenesulfonamideIUPAC名
C10H10N4O2S化学式
250.28 g/mol分子量
sulfadiazine; 68-35-9; Sulphadiazine; Sulfapyrimidine; Sulfadiazin; Adiazine; Coco-Diazine; 2-Sulfanilamidopyrimidine; Sulfolex; Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-; 2-Sulfanilylaminopyrimidine; 4-amino-N-pyrimidin-2-ylbenzenesulfonamide; N(1)-2-pyrimidylsulfanilamide; N(sup 1)-2-Pyrimidinylsulfanilamide; 4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide; N(1)-2-pyrimidinylsulfanilamide; 4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE; DTXSID7044130; CHEBI:9328; NSC35600; 0N7609K889; DTXCID5024130; Sulfadiazine, Zinc; Sulfadiazine Base; RefChem:6268; 200-685-8; Sulfacombin; Pyrimal; Sulfadiazene; Sulfazine; Debenal; Cremodiazine; Sulfapyrimidin; Adiazin; Diazin; Honey diazine; Liquadiazine; Spofadrizine; Theradiazine; Cremotres; Deltazina; Diazolone; Eskadiazine; Microsulfon; Neotrizine; Palatrize; Piridisir; Quadetts; Quadramoid; Sanodiazine; Sterazine; Sulfatryl; Sulfonsol; Terfonyl; Trifonamide; Truozine; Neazine; Pirimal; Sulfose; Trisem; Sulfanilamidopyrimidine; Lipo-Levazine; Tri-Sulfameth; Triple Sulfas; Lipo-Diazine; Metha-Meridiazine; Diazovit; Sulfadiazina; 4-amino-N-(pyrimidin-2-yl)benzenesulfonamide; Sulphadiazine E; Sulfadiazinum; Sulfapirimidin; Di-Azo-Mul; Thi-Di-Mer; Codiazine; Pecta-diazine, suspension; RP 2616; Pyrimidine, 2-sulfanilamido-; 2-Sulfapyrimidine; 4-amino-N-pyrimidin-2-yl-benzenesulfonamide; Sulfanilamide, N1-2-pyrimidinyl-; 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide; MFCD00006065; Sulfanilamide, N(sup 1)-2-pyrimidinyl-; 4-Amino-N-2-pyrimidinyl-benzenesulfonamide; N(sup1)-2-Pyrimidylsulfanilamide; Sulfanilamide, N1-2(1H)-pyrimidinylidene-; A-306; N(sup1)-2-Pyrimidinylsulfanilamide; CHEMBL439; S. N. 112; NSC-35600; CAS-68-35-9; NCGC00016305-01; Solfadiazina; TRISULFAPYRIMIDINES (SULFADIAZINE); CocoDiazine; Solfadiazina [DCIT]; [(4-aminophenyl)sulfonyl]pyrimidin-2-ylamine; 2-Sulfanilamidopyrimidin; Sulfapyrimidin [German]; Benzenesulfonamide, 4-amino-N-(2-pyrimidinyl)-; SDZ; Sulfadiazinum [INN-Latin]; Sulfadiazina [INN-Spanish]; S.N. 112; 2-Sulfanilamidopyrimidin [German]; A-306 (VAN); A 306; SMR000059113; N-(2-Pyrimidinyl)sulfanilamide; rBPI21 & Sulfa; SR-01000002973; EINECS 200-685-8; NSC 35600; 2-Sulfanilamido-pyrimidine; BRN 0235192; diazine; ulfadiazine; CRL-8131 & Sulfadiazine; N1-2-Pyrimidinylsulfanilamide; Sulfadiazine (JAN/USP/INN); Sulfadiazine;; Neotrizine;; AI3-01047; Lantrisul;; Sulfaloid;; Terfonyl;; Sulfose;; Triple Sulfas;; Sulfadiazine CRS; Triple Sulfa;; Trisulfapyrimidine, oral suspension; UNII-0N7609K889; Sulfadiazine [USP:INN:BAN:JAN]; Prestwick_428; Sulfonamides Duplex;; RP-2616; Spectrum_000986; Sulfadiazina Reig Jofre; Sulfadiazine (Standard); Sulfacombin (Salt/Mix); Prestwick0_000023; Prestwick1_000023; Prestwick2_000023; Prestwick3_000023; Spectrum2_001319; Spectrum3_001362; Spectrum4_000342; Spectrum5_000992; SULFADIAZINE [MI]; SULFADIAZINE [INN]; SULFADIAZINE [JAN]; Epitope ID:140083; N1-2-Pyrimidylsulfanilamide; Sulfadiazine, >=99.0%; SULFADIAZINE [VANDF]; Oprea1_081078; SCHEMBL24176; BSPBio_000085; BSPBio_002884; KBioGR_000743; KBioSS_001466; SULFADIAZINE [MART.]; 5-25-10-00067 (Beilstein Handbook Reference); MLS000069423; MLS006011457; 720 - Sulfonamides in fish; DivK1c_000543; pyrimidine, 2-sulphanilamido-; SPECTRUM1500546; SULFADIAZINE [USP-RS]; SULFADIAZINE [WHO-DD]; SPBio_001417; SPBio_002006; BPBio1_000095; orb1224253; orb1310158; orb3025073; WLN: T6N CNJ BMSWR DZ; GTPL12635; HMS501L05; HY-B0273R; KBio1_000543; KBio2_001466; KBio2_004034; KBio2_006602; KBio3_002104; MSK4017; SULFADIAZINE [GREEN BOOK]; NINDS_000543; GLXC-25873; HMS1568E07; HMS1921A13; HMS2090P09; HMS2092I15; HMS2095E07; HMS2235D19; HMS3371L19; HMS3655I10; HMS3712E07; HMS5080A05; Pharmakon1600-01500546; SULFADIAZINE [ORANGE BOOK]; SULFADIAZINE [EP MONOGRAPH]; SULFADIAZINE [USP IMPURITY]; ALBB-014888; HY-B0273; MSK4017-1000DM; SULFADIAZINE [USP MONOGRAPH]; Tox21_110360; BBL013169; BDBM50166571; CCG-39257; EBC-03731; MSK4017-100M; NSC757324; Recombinant bactericidal/permeability-increasing protein & Sulfadiazine; s1770; SBB007604; SBB057674; STK317797; SULFOSE COMPONENT SULFADIAZINE; TERFONYL COMPONENT SULFADIAZINE; 2-(p-Aminobenzenesulfonamido)pyrimidin; AKOS000119073; LANTRISUL COMPONENT SULFADIAZINE; SULFALOID COMPONENT SULFADIAZINE; AS29662; DB00359; KS-1144; NSC-757324; 2-(4-Aminobenzenesulfonamido)pyrimidine; 4-amino-N-2-pyrimidylbenzenesulfonamide; IDI1_000543; NEOTRIZINE COMPONENT SULFADIAZINE; NCGC00016305-02; NCGC00016305-03; NCGC00016305-04; NCGC00016305-05; NCGC00016305-06; NCGC00016305-09; NCGC00016305-10; NCGC00016305-11; NCGC00023291-03; NCGC00023291-04; SULFADIAZINE (TRISULFAPYRIMIDINES); 2-(4-Aminobenzenesulfonylamino)pyrimidine; AC-26817; AS182571; ST059447; Sulfadiazine 100 |Ig/mL in Acetonitrile; Sulfadiazine, 100 microg/mL in methanol; Sulfadiazine; Sulfadimidine EP Impurity B; 4-amino-N-2-pyrimidinyl benzenesulfonamide; SBI-0051520.P003; Sulfadiazine 100 microg/mL in Acetonitrile; TRIPLE SULFOID COMPONENT SULFADIAZINE; 4-[[(Pyrimidin-2-yl)amino]sulfonyl]aniline; AB00052095; NS00000198; S0579; ST51006797; Sulfadiazine 1000 microg/mL in Acetonitrile; Sulfadiazine Solution in Methanol, 100ug/mL; SW196657-3; 4-amino-N-(2-pyrimidinyl) benzenesulfonamide; EN300-19076; SULFADIMIDINE IMPURITY B [EP IMPURITY]; 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide #; C07658; D00587; D92267; SBI-0051520.0001; Trisulfapyrimidine, oral suspension (Salt/Mix); AB00052095-13; AB00052095-14; AB00052095_15; AB00052095_16; Sulfadiazine, VETRANAL(TM), analytical standard; F358229; F572241; Sulfadiazine for identification of impurity F CRS; Q2555060; SR-01000002973-2; SR-01000002973-3; Sulfadiazine Solution in DMSO/Methanol, 1000ug/mL; BRD-K32273377-001-05-4; BRD-K32273377-001-09-6; BRD-K32273377-001-15-3; BRD-K32273377-001-16-1; BRD-K32273377-001-17-9; 4-AMINO-N-(2-PYRIMIDINYL)-1-BENZENESULFONAMIDE; F1657-1720; Sulfadiazine, certified reference material, TraceCERT(R); TRISULFAPYRIMIDINES (SULFADIAZINE) [ORANGE BOOK]; Z104472626; Sulfadiazine, European Pharmacopoeia (EP) Reference Standard; Sulfadiazine, United States Pharmacopeia (USP) Reference Standard; 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide, N1-(Pyrimidin-2-yl)sulfanilamide; Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material; Sulfadiazine for identification of impurity F, European Pharmacopoeia (EP) Reference Standard別名
